Abstract
The oxime reactivator K112 is a member of the new group of xylene linker-containing AChE reactivators. Its cholinergic properties could be of importance at OP poisoning and are not related to the AChE reactivation that has been studied. It has been found that, despite of reactivating potency, this compound has additional effects. These cholinergic effects include a weak inhibition of AChE (IC(50)=43.8 ± 4.88 μM), inhibition of binding to the porcine muscarinic M2 receptor (IC(50)=4.36 μM) and finally, the inhibition of HACU (68.4 ± 9.9%), a key regulatory step in the synthesis of ACh. The inhibition of the binding of (3H)-HC-3 (64.7 ± 4.7%) and the influence on the membrane fluidity have also been observed. Blocking properties of K112 on the muscarinic receptors have been revealed in the in vitro experiment (rat urinary bladder) and in the in vivo experiment (rat heart BPM) as well. All these cholinergic properties could significantly contribute to the antidotal effect of K112 at the poisoning by the organophosphates.
References
Apr 29, 1991·Neuroscience Letters·J Musílková, S Tucek
Jan 1, 1989·Archives of Toxicology·M G Hamilton, P M Lundy
Jan 1, 1985·Journal of Neurochemistry·S Tucek
Apr 1, 1993·British Journal of Pharmacology·J E Tattersall
Jan 1, 1996·Archives of Toxicology·H P van HeldenP L Bruijnzeel
Mar 21, 2001·Methods and Findings in Experimental and Clinical Pharmacology·H OguraY Yamanishi
Dec 26, 2001·Pharmacology & Therapeutics·N R Zahniser, S Doolen
Jun 18, 2002·European Journal of Pharmacology·Weng-Keong LokeMei-Lin Go
Dec 12, 2002·Journal of Toxicology. Clinical Toxicology·J Kassa
Jul 1, 1961·Biochemical Pharmacology·G L ELLMANR M FEATHER-STONE
Jun 22, 2005·European Journal of Pharmacology·Ole Kristian ØydvinPål Aas
Sep 15, 2005·Molecular Pharmacology·Christian TränkleKlaus Mohr
Dec 13, 2005·Journal of Enzyme Inhibition and Medicinal Chemistry·K MusilekM Dolezal
Dec 30, 2006·Journal of Enzyme Inhibition and Medicinal Chemistry·Martina HrabinovaKamil Kuca
Jan 25, 2007·Basic & Clinical Pharmacology & Toxicology·Daniel GiglioGunnar Tobin
Feb 10, 2007·Toxicological Reviews·Paul M LundyGabriel Amitai
Mar 27, 2007·Bioorganic & Medicinal Chemistry Letters·Kamil MusilekMartin Dolezal
Sep 13, 2007·Journal of Enzyme Inhibition and Medicinal Chemistry·Kamil MusilekMartin Dolezal
Jul 12, 2008·Chemico-biological Interactions·D JunJ Bajgar
Nov 7, 2008·Neuro Endocrinology Letters·Ondrej SoukupKamil Kuca
Apr 22, 2016·Toxicology Mechanisms and Methods·Jiri KassaJohn E H Tattersall
Citations
Nov 28, 2012·Archives of Toxicology·O SoukupK Kuca
Jul 27, 2011·Environmental Toxicology and Pharmacology·O SoukupG Tobin
Jan 5, 2011·Toxicology Letters·Zdeněk FišarKamil Kuča
Nov 20, 2014·Journal of Biomolecular Structure & Dynamics·Juliana O S GiacoppoTeodorico C Ramalho
Jun 12, 2012·Toxicology Letters·O SoukupK Kuca
Jul 15, 2016·Molecular BioSystems·J JanockovaM Kozurkova
Feb 8, 2019·Scientific Reports·Vesna JaćevićKamil Kuča